Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 22 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-4.81 Insider Own0.14% Shs Outstand4.86M Perf Week-2.68%
Market Cap8.43M Forward P/E- EPS next Y-3.37 Insider Trans0.00% Shs Float4.85M Perf Month-9.67%
Income-23.37M PEG- EPS next Q-0.97 Inst Own0.80% Short Float0.43% Perf Quarter-1.53%
Sales6.86M P/S1.23 EPS this Y31.20% Inst Trans27.47% Short Ratio1.49 Perf Half Y-36.20%
Book/sh5.41 P/B0.32 EPS next Y-4.66% ROA-42.84% Short Interest0.02M Perf Year-49.88%
Cash/sh7.98 P/C0.22 EPS next 5Y- ROE-61.74% 52W Range1.36 - 3.45 Perf YTD-6.76%
Dividend Est.- P/FCF- EPS past 5Y30.08% ROI-88.69% 52W High-49.73% Beta1.56
Dividend TTM- Quick Ratio9.89 Sales past 5Y134.93% Gross Margin94.54% 52W Low27.51% ATR (14)0.11
Dividend Ex-Date- Current Ratio9.91 EPS Y/Y TTM-77.43% Oper. Margin-229.36% RSI (14)42.19 Volatility6.40% 5.16%
Employees21 Debt/Eq0.01 Sales Y/Y TTM66.92% Profit Margin-340.56% Recom1.00 Target Price15.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-21.20% Payout- Rel Volume0.87 Prev Close1.78
Sales Surprise-100.00% EPS Surprise-39.34% Sales Q/Q-99.84% EarningsNov 09 BMO Avg Volume14.14K Price1.73
SMA20-4.55% SMA50-10.13% SMA200-25.89% Trades Volume12,290 Change-2.57%
Date Action Analyst Rating Change Price Target Change
Jul-19-17Reiterated Maxim Group Buy $2 → $4
May-10-17Reiterated H.C. Wainwright Buy $7.50 → $3
May-01-17Reiterated Maxim Group Buy $11 → $2
Jan-17-17Reiterated Maxim Group Buy $7 → $10
Dec-02-15Reiterated H.C. Wainwright Buy $11 → $12
Nov-24-15Reiterated H.C. Wainwright Buy $0.11 → $11
Nov-23-15Reiterated Maxim Group Buy $200 → $11
Apr-14-15Upgrade H.C. Wainwright Neutral → Buy $1.25
Nov-06-14Downgrade H.C. Wainwright Buy → Neutral
Jul-17-14Initiated H.C. Wainwright Buy $3
Feb-15-24 05:50PM
Dec-14-23 08:16AM
Nov-09-23 08:32AM
08:00AM Loading…
Oct-18-23 10:00AM
Oct-11-23 08:00AM
Sep-05-23 08:00AM
Aug-09-23 09:40AM
Jul-13-23 07:30AM
Jul-05-23 08:45AM
Jun-14-23 04:05PM
04:05PM Loading…
May-15-23 04:05PM
May-10-23 05:03AM
May-09-23 05:00PM
Apr-06-23 10:15AM
Apr-05-23 07:55AM
Mar-23-23 09:25AM
Mar-16-23 08:05AM
Feb-23-23 09:40AM
Feb-07-23 09:40AM
Jan-17-23 12:53PM
Jan-11-23 01:00PM
Jan-10-23 08:05AM
10:15AM Loading…
Nov-03-22 10:15AM
Aug-29-22 08:00AM
Aug-03-22 05:30PM
Jul-28-22 10:02AM
Jul-18-22 05:06PM
Jul-15-22 04:15PM
Jul-06-22 04:05PM
Jun-21-22 04:01PM
Jun-13-22 08:00AM
Jun-09-22 08:00AM
Jun-03-22 06:58AM
May-25-22 08:00AM
May-18-22 08:00AM
May-16-22 08:00AM
May-12-22 08:05AM
May-11-22 08:05AM
May-02-22 08:25AM
Apr-25-22 08:05AM
Apr-19-22 08:05AM
Apr-13-22 10:45AM
Apr-12-22 08:05AM
Apr-11-22 08:05AM
Mar-29-22 08:00AM
Mar-21-22 05:15PM
Mar-17-22 08:25AM
Mar-15-22 09:15AM
Mar-10-22 07:05AM
Mar-02-22 08:05AM
Mar-01-22 09:05AM
Feb-07-22 08:05AM
Feb-04-22 01:38PM
Jan-26-22 04:05PM
Jan-20-22 08:05AM
Jan-12-22 10:35AM
Jan-05-22 08:36AM
Dec-25-21 08:31AM
Dec-23-21 04:05PM
Nov-04-21 04:05PM
Oct-21-21 07:30PM
Oct-20-21 07:30PM
Oct-01-21 12:46PM
Sep-26-21 08:02AM
Sep-08-21 08:00AM
Aug-04-21 04:05PM
Jul-29-21 08:05AM
Jun-28-21 01:56AM
Jun-13-21 02:10PM
Jun-07-21 08:05AM
Jun-03-21 08:05AM
May-18-21 12:30PM
May-17-21 10:12AM
May-13-21 09:33AM
May-10-21 08:05AM
May-06-21 08:05AM
May-05-21 04:35PM
May-03-21 08:05AM
Apr-28-21 08:05AM
Mar-30-21 02:23AM
Mar-25-21 08:05AM
Mar-22-21 04:05PM
Mar-15-21 09:11AM
Mar-11-21 08:05AM
Aeterna Zentaris, Inc. is a specialty biopharmaceutical company, which engages in the development and commercialization of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.